Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

May 31, 2014

Conditions
Renal Osteodystrophy
Interventions
DRUG

Zoledronic acid

The treatment group will receive 15-minute intravenous administration of zoledronic acid (5 mg) in a single dose at the time of kidney transplantation and vitamin D replacement. The aim of vitamin D replacement will be serum levels of 25 (OH) vitamin D above 30 ng/ml.

Trial Locations (1)

05403-900

Hospital das Clinicas - Faculdade de Medicina da Universidade de São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT01675089 - Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation | Biotech Hunter | Biotech Hunter